+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

The role of methodology for purging tumor from autologous bone marrow and peripheral blood progenitor cells



The role of methodology for purging tumor from autologous bone marrow and peripheral blood progenitor cells



Medical Oncology 11(2): 47-51




(PDF emailed within 1 workday: $29.90)

Accession: 033929679

Download citation: RISBibTeXText


Related references

The role and methodology for purging tumor from autologous bone marrow and peripheral blood progenitor cells. Medical Oncology 11(2): 47-51, 1994

Future paradigm for autologous bone marrow transplantation: tumor purging and ex vivo production of normal stem and progenitor cells. Journal of HematoTherapy 3(3): 213-218, 1994

G-CSF primed peripheral blood progenitor cells in autologous bone marrow transplantation: parameters affecting bone marrow engraftment. Bone Marrow Transplantation 12(6): 609-614, 1993

Purging of autologous bone marrow and peripheral blood stem cells in patients with BCR/ABL-positive acute lymphoblastic leukemia. Annals of Hematology 77(SUPPL 2): S163, 1998

Comparison of G-CSF with GM-CSF for mobilizing peripheral blood progenitor cells and for enhancing marrow recovery after autologous bone marrow transplant. Bone Marrow Transplantation 14(6): 913-918, 1994

Marrow purging in autologous bone marrow transplantation for t lineage acute lymphoblastic leukemia efficacy of ex vivo treatment with immunotoxins and 4 hydroperoxycyclophosphamide against fresh leukemic marrow progenitor cells. Blood 69(1): 361-366, 1987

A comparison of G-CSF with GM-CSF for mobilization of peripheral blood progenitor cells and for enhancement of marrow recovery post autologous bone marrow transplant. Blood 82(10 SUPPL 1): 83A, 1993

Purging tumor cells from bone marrow or peripheral blood using avidin-biotin immunoadsorption. Progress in Clinical and Biological Research 389: 97-103, 1994

Purging of tumor cells from bone marrow and peripheral blood stem cell harvests. Transfusion 32(8 SUPPL ): 1S, 1992

High-dose chemotherapy for breast cancer: clinical advantages of autologous peripheral blood progenitor cells (PBPC) compared with autologous bone marrow transplantation (ABMT). Annals of Oncology 6 Suppl 4: 33-37, 1995

Autologous peripheral blood progenitor cells transplantation in patients with malignant lymphoma A retrospective cost comparison with autologous bone marrow transplantation. British Journal of Haematology 87(SUPPL 1): 24, 1994

Immunomagnetic bone marrow and peripheral blood progenitor cell purging in follicular lymphoma. Bone Marrow Transplantation 23(6): 579-587, March 2, 1999

Combined autologous peripheral blood progenitor cells and bone marrow stem cells transplantation in the treatment of hematological malignancies. Experimental Hematology 25(8): 819, 1997

Expression of GPIIb/IIIa on progenitor cells in peripheral blood and bone marrow harvested for autologous transplantation. Clinical Research 42(2): 236A, 1994

Usefulness of lymphokine-activated killer cells generated from bone marrow mononuclear cells for the purging of residual tumor cells in peripheral blood stem cell graft. Japanese Journal of Cancer Research 87(2): 161-169, 1996